About Micromedex NeoFax Reference
Micromedex NeoFax Reference is a reliable resource for on-the-go access to evidence-based drug information to efficiently and safely manage drug therapy for neonatal patients. It allows clinicians to make accurate and...
Micromedex NeoFax Reference is a reliable resource for on-the-go access to evidence-based drug information to efficiently and safely manage drug therapy for neonatal patients. It allows clinicians to make accurate and more informed treatment decisions at the point of care, while minimizing errors in this vulnerable patient population. This neonatal-specific app has clinical value for doctors, nurses, and pharmacists. An internet connection is not required, allowing you to make decisions with confidence at anytime, from anywhere.
Merative Micromedex® is a trusted source for neonatal drug dosing, based on the strict editorial policies and practices that have guided Merative Micromedex® for more than 30 years. Evidence-based, fully referenced neonatal-specific drug information enables clinicians to make informed treatment decisions. The drug monographs cover information including: dose, administration, uses, contraindications/precautions, adverse effects, monitoring, pharmacology, special considerations/preparation, solution- and drug-drug compatibility/incompatibility information, and references. This mobile app also includes a comprehensive enteral formulas component providing nutritional information for approximately 60 different neonatal and infant formulas, and human milk fortifiers.
Micromedex NeoFax Reference drug information is intended for full-term babies up to 28 days of age (PNA) and preterm babies up to 44 weeks postmenstrual age (GA + PNA).
Do you work at a facility that subscribes to Merative Micromedex® NeoFax®? Check with your Chief of Pediatrics, Director of Pediatrics, Director of the NICU, Directory of Pharmacy, Chief Medical Officer, Chief Nursing Officer, Medical Librarian, or anyone else at your facility responsible for clinical reference information.
If you work at a facility that subscribes to Merative Micromedex® NeoFax®, FREE access to these apps requires a password. To obtain the Micromedex NeoFax password contact support at https://merative.my.site.com/mysupport/s/micromedex-support-request
Previous Versions
Here you can find the changelog of Micromedex NeoFax Reference since it was posted on our website on 2023-06-12 16:30:58.
The latest version is 4.5.1 and it was updated on 2024-04-19 18:21:47. See below the changes in each version.
Micromedex NeoFax Reference version 4.5.1
Updated At: 2023-12-06
Changes: Bug fixes
Micromedex NeoFax Reference version 4.2.0
Updated At: 2023-06-14
Changes: Updated new SSL certificate public key
Micromedex NeoFax Reference version 4.1.0
Updated At: 2022-11-25
Changes: Updates to the app to reflect the new company branding
Disclaimer
Official Google Play Link
We do not host Micromedex NeoFax Reference on our servers. We did not scan it for viruses, adware, spyware or other type of malware. This app is hosted by Google and passed their terms and conditions to be listed there. We recommend caution when installing it.
The Google Play link for Micromedex NeoFax Reference is provided to you by apps112.com without any warranties, representations or guarantees of any kind, so access it at your own risk.
If you have questions regarding this particular app contact the publisher directly. For questions about the functionalities of apps112.com contact us.
